{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:23:35Z","timestamp":1786123415792,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bone.2026.117993","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:51:34Z","timestamp":1782715894000},"page":"117993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Systemic and local predictors of medication-related osteonecrosis of the jaw in patients receiving antiresorptive therapy: The Shizuoka Kokuho Database study"],"prefix":"10.1016","volume":"211","author":[{"given":"Kanako","family":"Tsuboi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2026.117993_bb0005","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaw\u20132014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2026.117993_bb0010","article-title":"Comparison of the effectiveness of conservative and surgical treatment of medication-related osteonecrosis of the jaw: a systematic review","volume":"14","author":"Seluki","year":"2023","journal-title":"J. Oral Maxillofac. Res."},{"key":"10.1016\/j.bone.2026.117993_bb0015","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/jbmr.3191","article-title":"Evaluation of the treatment strategies for medication-related osteonecrosis of the jaws (MRONJ) and the factors affecting treatment outcome: a multicenter retrospective study with propensity score matching analysis","volume":"32","author":"Hayashida","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117993_bb0020","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws\u20132022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2026.117993_bb0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40780-015-0035-2","article-title":"Analysis of the time-to-onset of osteonecrosis of jaw with bisphosphonate treatment using the data from a spontaneous reporting system of adverse drug events","volume":"1","author":"Nakamura","year":"2015","journal-title":"J. Pharm. Health Care Sci."},{"key":"10.1016\/j.bone.2026.117993_bb0030","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025600","article-title":"Database analysis of the risk factors of bisphosphonate-related osteonecrosis of the jaw in Hungarian patients","volume":"9","author":"Veszelyn\u00e9 Kot\u00e1n","year":"2019","journal-title":"BMJ Open"},{"issue":"2023","key":"10.1016\/j.bone.2026.117993_bb0035","first-page":"1101","article-title":"To 2020 in Kure, Japan","volume":"34","author":"T. Kunihara, H. Tohmori, M. Tsukamoto, M. Kobayashi, T. Okumura, H. Teramoto, T. Hamasaki, T. Yamasaki, T. Nakagawa, N. Okimoto, S. Fujiwara, Incidence and trend of antiresorptive agent-related osteonecrosis of the jaw from","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2026.117993_bb0040","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.3390\/jcm10204762","article-title":"Cancer patients at risk for medication-related osteonecrosis of the jaw. A case and control study analyzing predictors of MRONJ onset","volume":"10","author":"Marcian\u00f2","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bone.2026.117993_bb0045","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.bjoms.2024.08.008","article-title":"Management of medication-related osteonecrosis of the jaw: an overview of national and international guidelines","volume":"62","author":"Patel","year":"2024","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2026.117993_bb0050","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00774-020-01195-x","article-title":"Oral risk factors associated with medication-related osteonecrosis of the jaw in patients with cancer","volume":"39","author":"Ueda","year":"2021","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2026.117993_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2023.116722","article-title":"Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents \u2013 a retrospective study of 240 patients","volume":"170","author":"Coropciuc","year":"2023","journal-title":"Bone"},{"key":"10.1016\/j.bone.2026.117993_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96480-8","article-title":"Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients","volume":"11","author":"Soutome","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bone.2026.117993_bb0065","doi-asserted-by":"crossref","first-page":"18317","DOI":"10.1002\/cam4.6429","article-title":"A real-world study on the prevalence and risk factors of medication-related osteonecrosis of the jaw in cancer patients with bone metastases treated with Denosumab","volume":"12","author":"Bracchi","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.bone.2026.117993_bb0070","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1186\/s12903-025-06741-5","article-title":"Endodontic therapy and medication-related osteonecrosis of the jaw onset: a scoping review and expert opinion-based qualitative meta-synthesis","volume":"25","author":"Mauceri","year":"2025","journal-title":"BMC Oral Health"},{"key":"10.1016\/j.bone.2026.117993_bb0075","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.oooo.2018.02.003","article-title":"Medication-related osteonecrosis of the jaw: an update on the Memorial Sloan Kettering Cancer Center experience and the role of premedication dental evaluation in prevention","volume":"125","author":"Owosho","year":"2018","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"10.1016\/j.bone.2026.117993_bb0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.oraloncology.2018.08.003","article-title":"Risk-reductive dental strategies for medication-related osteonecrosis of the jaw among cancer patients: a systematic review with meta-analyses","volume":"85","author":"Karna","year":"2018","journal-title":"Oral Oncol."},{"key":"10.1016\/j.bone.2026.117993_bb0085","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.joms.2021.12.007","article-title":"Prevalence, incidence rate, and risk factors of medication-related osteonecrosis of the jaw in patients with osteoporosis and cancer: a nationwide population-based study in Japan","volume":"80","author":"Ishimaru","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2026.117993_bb0090","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12982-018-0080-z","article-title":"Clarifying questions about \u201crisk factors\u201d: predictors versus explanation","volume":"15","author":"Schooling","year":"2018","journal-title":"Emerg. Themes Epidemiol."},{"key":"10.1016\/j.bone.2026.117993_bb0095","author":"Shizuoka Graduate University of Public Health"},{"key":"10.1016\/j.bone.2026.117993_bb0100","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2188\/jea.JE20200480","article-title":"Data resource profile of Shizuoka Kokuho database (SKDB) using integrated health- and care-insurance claims and health checkups: the Shizuoka study","volume":"32","author":"Nakatani","year":"2022","journal-title":"J. Epidemiol."},{"key":"10.1016\/j.bone.2026.117993_bb0105","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(11)60828-3","article-title":"Japanese universal health coverage: evolution, achievements, and challenges","volume":"378","author":"Ikegami","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2026.117993_bb0110","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1186\/s12913-021-07135-3","article-title":"Validity of diagnoses and procedures in Japanese dental claims data","volume":"21","author":"Ono","year":"2021","journal-title":"BMC Health Serv. Res."},{"issue":"2017","key":"10.1016\/j.bone.2026.117993_bb0115","first-page":"6","article-title":"Of the Japanese allied committee on osteonecrosis of the jaw","volume":"35","author":"T. Yoneda, H. Hagino, T. Sugimoto, H. Ohta, S. Takahashi, S. Soen, A. Taguchi, T. Nagata, M. Urade, T. Shibahara, S. Toyosawa, Antiresorptive agent-related osteonecrosis of the jaw: position paper","year":"2017","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2026.117993_bb0120","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1038\/s41440-024-01660-4","article-title":"Risk of cancer history in cardiovascular disease among individuals with hypertension","volume":"47","author":"Suzuki","year":"2024","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.bone.2026.117993_bb0130","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/ijc.35439","article-title":"Molecular targeted drugs affect the development of antiresorptive-related osteonecrosis of the jaw in patients with lung and kidney cancers","volume":"157","author":"Kanno","year":"2025","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bone.2026.117993_bb0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/EDE.0000000000001432","article-title":"On the nature of informative presence bias in analyses of electronic health records","volume":"33","author":"McGee","year":"2022","journal-title":"Epidemiology"},{"key":"10.1016\/j.bone.2026.117993_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/1348-9585.12104","article-title":"Association between dental consultation and oral health status among male Japanese employees","volume":"62","author":"Shimazaki","year":"2020","journal-title":"J. Occup. Health"},{"key":"10.1016\/j.bone.2026.117993_bb0145","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/jbmr.4472","article-title":"Risk of osteonecrosis of the jaw under denosumab compared to bisphosphonates in patients with osteoporosis","volume":"37","author":"Everts-Graber","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117993_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-02225-2","article-title":"Incidence of medication-related osteonecrosis of the jaw and associated antiresorptive drugs in adult Finnish population","volume":"15","author":"Kujanp\u00e4\u00e4","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bone.2026.117993_bb0155","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.pmrj.2011.02.017","article-title":"Adverse effects of corticosteroids on bone metabolism: a review","volume":"3","author":"Mitra","year":"2011","journal-title":"PM R"},{"key":"10.1016\/j.bone.2026.117993_bb0160","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bone.2026.117993_bb0165","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.3390\/ijms24086891","article-title":"Iron deficiency and iron deficiency anemia: potential risk factors in bone loss","volume":"24","author":"Yang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bone.2026.117993_bb0170","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bone.2026.117993_bb0175","first-page":"e326","article-title":"Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab vs. zoledronic acid: a systematic review and meta-analysis, med. Oral Patol. Oral","volume":"25","author":"Limones","year":"2020","journal-title":"Cir. Bucal"},{"key":"10.1016\/j.bone.2026.117993_bb0180","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/odi.12632","article-title":"Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study","volume":"23","author":"Fung","year":"2017","journal-title":"Oral Dis."},{"key":"10.1016\/j.bone.2026.117993_bb0185","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1111\/odi.14887","article-title":"Italian position paper (SIPMO-SICMF) on medication-related osteonecrosis of the jaw (MRONJ)","volume":"30","author":"Bedogni","year":"2024","journal-title":"Oral Dis."},{"key":"10.1016\/j.bone.2026.117993_bb0190","first-page":"1","article-title":"The dental management of patients at risk of medication-related osteonecrosis of the jaw: new paradigm of primary prevention","volume":"2018","author":"Di Fede","year":"2018","journal-title":"Biomed. Res. Int."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632822600219X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632822600219X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:41:28Z","timestamp":1786117288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S875632822600219X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"alternative-id":["S875632822600219X"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2026.117993","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic and local predictors of medication-related osteonecrosis of the jaw in patients receiving antiresorptive therapy: The Shizuoka Kokuho Database study","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2026.117993","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117993"}}